This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINZESS 145 MCG capsules. The contract has a ceiling value of $1,882.29 and a completion date of September 17, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of LINZESS 145 MCG capsules. The contract has a firm fixed price of $4,196.85 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of pharmaceutical and medical supplies to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LINZESS 145 MCG capsules and has a ceiling value of $3,725.28. The contract is a firm fixed-price delivery order with a completion date of May 8, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The award is for the pharmaceutical product LINZESS 145 MCG CAPSULE in 30-count units, with a ceiling value of $2,635.63 and a performance period through April 5, 2024. Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, specializes in providing pharmaceuticals and medical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 145 mcg LINZESS capsules, a prescription medication. The contract has a ceiling value of $1,841.60 and a period of performance through March 12, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,534.58 firm fixed-price contract is for the delivery of LINZESS 145 MCG CAPSULE medication and has a completion date of June 3, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,063.29, is for the delivery of LINZESS 290 MCG CAPSULE medical products. It is a firm fixed-price contract with a completion date of March 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The $6,145.84 firm fixed-price contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product. The contract has an ultimate completion date of December 21, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly within military and...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LINZESS 290 MCG capsules, with a ceiling value of $1,056.42 and a performance period through February 9, 2022. AmerisourceBergen Drug Corp serves as the prime contractor, providing pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,704.54 firm fixed price contract is for the delivery of LINZESS 145 MCG capsules. The contract has an ultimate completion date of October 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies. This order is likely part of a larger indefinite...